DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Pharmacovigilance" conference to their offering.
Understanding PhV today - a basic training course on the principles and practice of global PhV for those working in Drug safety.
This course aims to provide basic training for those concerned with pharmacovigilance. New entrants as well as experienced operators in drug safety monitoring will benefit from the mixture of scientific knowledge and practical guidance. In addition, detailed information will be provided on regulatory developments in pharmacovigilance in Europe, the USA, and Japan.
Agenda
Day One
Chairman: Prof. Saad Shakir
09.30 Principles of Pharmacovigilance and Data Resources
10.30 Refreshments
10.45 Risk Management and Risk Minimisation: Basic Principles
11.30 Causality Assessment: Clinical Diagnosis of Adverse Events
12.30 Discussion followed by Lunch
Chairman: Shelley Gandhi
14.00 The Current Regulatory Framework and its Global Impact
15.30 Refreshments
15.45 European Post-Marketing Pharmacovigilance Regulations
17.15 End of Day One and Drinks Reception
Day Two
Chairman: Dr John Talbot
09.00 Pro-active Pharmacovigilance Pre- and Post Marketing
10.00 Discussion
10.10 Risk/Benefit Assessment
11.10 Discussion
11.15 Refreshments
11.30 Clinical Trial ADR Reporting Requirements
12.35 Discussion followed by Lunch
14.00 Pharmacoepidemiological Studies - Basic Designs, Strengths, Weaknesses and Examples
15.30 Refreshments
15.45 Where are we now with PSURs (or PBRERs)?
16.45 Discussion
17.00 End of Day Two
Day Three
09.00 Drug Surveillance in Countries Outside Europe
10.15 Practicalities of Signal Detection
11.00 Refreshments
11.15 Examples of Pharmacoepidemiological Studies Used in Risk Management
12.15 Practicalities of Risk Management: A real world example of the development of a successful EU risk management plan
13.00 Lunch
14.15 Practical Pharmacovigilance Workshop
16.00 End of conference and Refreshments
For more information about this conference visit http://www.researchandmarkets.com/research/6vwp9x/pharmacovigilance
